Tag: Eli Lilly
FDA approves new Alzheimer’s drug Kisunla by Eli Lilly for use in early stages of disease
The Food and Drug Administration (FDA) has recently given the green light to a new Alzheimer's drug, Kisunla, for use in the early stages of[more...]
Diabetes and Weight Loss Drugs Linked to Reduced Cancer Risk
A class of diabetes and weight loss drugs, including Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro, is reported to potentially reduce the risk of cancer[more...]
Supply Trackers Introduced to Help Patients During Shortages of Popular Diabetes and Weight Loss Drugs
As Novo Nordisk and Eli Lilly grapple with the exponential demand for their widely sought-after drugs for diabetes and weight loss, the healthcare industry is[more...]
FDA Grants Approval for Zepbound (Tirzepatide) Injection: A Breakthrough in Weight Loss
In a significant stride towards combating the growing epidemic of obesity and overweight in the United States, the US Food and Drug Administration (FDA) has[more...]
US and UK Regulators Approve Eli Lilly’s Revolutionary Weight-Loss Drug, Zepbound
In a significant stride towards combating the global obesity epidemic, the US Food and Drug Administration (FDA) and the UK regulatory authority have given their[more...]
